Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-04-29
2008-04-29
Mondesi, Robert B. (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S007100
Reexamination Certificate
active
07365050
ABSTRACT:
The present invention provides a method of reducing or preventing a drug-related effect or behavior in a subject by inhibiting N-type calcium channels. In addition, the invention provides a variety of prescreening and screening methods aimed at identifying agents that modulate a drug-related effect or behavior. These methods involve assaying test agent binding to N-type calcium channels or channel subunits. Alternatively, test agents can be screened for their ability to alter the level of N-type calcium channels, channel subunit polypeptide or RNA, or the depolarization-induced inward calcium current mediated by these channels. Finally, the invention also provides a diagnostic method that entails measuring one or more of these levels and determining risk for a drug-related effect or behavior based on comparison to the corresponding level for a control population.
REFERENCES:
patent: 5859186 (1999-01-01), Justice et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6057332 (2000-05-01), Michne et al.
patent: 6267945 (2001-07-01), Zamponi
patent: 6310059 (2001-10-01), Snutch
patent: 6353091 (2002-03-01), Lipscombe et al.
patent: 6387897 (2002-05-01), Snutch
patent: 6492375 (2002-12-01), Snutch
patent: 6617322 (2003-09-01), Snutch
patent: 2004/0034035 (2004-02-01), Snutch et al.
patent: 2004/0044004 (2004-03-01), Snutch et al.
patent: WO 2005/015159 (2005-02-01), None
McMahon et al., PKC ε mediates up-regulation of N-type calcium channels by ethanol, 2000, Mol. Pharmacol. vol. 57, pp. 53-58.
Litten et al., Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings, J. Subst Abuse Treat. Mar. 1999, vol. 16, No. 2, pp. 105-112. Review.
Allgaier C. (2002) Ethanol sensitivity of NMDA receptors. Neurochem Int 41:377-382.
Beuckmann CT, Sinton CM, Miyamoto N, Ino M, Yanagisawa M (2003) N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences. J Neurosci 23:6793-6797.
Bowers BJ, Owen EH, Collins AC, Abeliovich A, Tonegawa S, Wehner JM (1999) Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background. Alcoholism, Clinical and Experimental Research 23:387-397.
Brooks SP, Hennebry G, McAlpin GP, Norman G, Little HJ (2002) Nimodipine prevents the effects of ethanol in tests of memory. Neuropharmacology 42:577-585.
Chester JA, Lumeng L, Li TK, Grahame NJ (2003) High- and low-alcohol-preferring mice show differences in conditioned taste aversion to alcohol. Alcohol Clin Exp Res 27:12-18.
Davies M. (2003) The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci 28:263-274.
De A, Boyadjieva NI, Sarkar DK (1999) Effect of voltage-dependent calcium channel blockers on ethanol-induced beta-endorphin release from hypothalamic neurons in primary cultures. Alcohol Clin Exp Res 23:850-855.
De Beun R, Schneider R, Klein A, Lohmann A, De Vry J (1996) Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats. Alcohol 13:263-271.
Dudek BC, Phillips TJ (1990) Distinctions among sedative, disinhibitory, and ataxic properties of ethanol in inbred and selectively bred mice. Psychopharmacology (Berl) 101:93-99.
Dunlap K, Luebke JI, Turner TJ (1995) Exocytotic Ca2+ channels in mammalian central neurons. Trends in Neurosciences 18:89-98.
Fadda F, Garau B, Colombo G, Gessa GL (1992) Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats. Alcoholism: Clinical and Experimental Research 16:449-452.
Gruner W. and Silva L. R. (1994) Omega-conotoxin sensitivity and presynaptic inhibition of glutamatergic sensory neurotransmission in vitro. J Neurosci 14:2800-2808.
Hjelmstad G. O. and Fields H. L. (2003) Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms. J Neurophysiol 89:2389-2395.
Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, Wang D, Sanchez-Perez AM, Messing RO (1999) Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCε. Nature Neuroscience 2:997-1002.
Kim C, Jun K, Lee T, Kim SS, McEnery MW, Chin H, Kim HL, Park JM, Kim DK, Jung SJ, Kim J, Shin HS (2001) Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel. Mol Cell Neurosci 18:235-245.
Kitamura G., Ohta T., Kai T., Kon Y. and Ito S. (2002) Inhibitory effects of opioids on voltage-dependent Ca(2+) channels and catecholamine secretion in cultured porcine adrenal chromaffin cells. Brain Res 942:11-22.
Krystal J. H., Petrakis I. L., Mason G., Trevisan L. and D'Souza D. C. (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99:79-94.
Kuzmin A, Semenova S, Zvartau E, De Vry J (1999) Effects of calcium channel blockade on intravenous self-administration of ethanol in rats. Eur Neuropsychopharmacol 9:197-203.
Little HJ (1995) The role of calcium channels in drug dependence. Drug Alcohol Depend 38:173-194.
Mackie and Hille (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci., USA 89:3825-29.
McMahon T, Anderson R, Metten P, Crabbe JC, Messing RO (2000) Protein kinase C epsilon mediates up-regulation of N-type calcium channels by ethanol. Molecular Pharmacology 57:53-58.
Momiyama T. and Koga E. (2001) Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones. J Physiol 533:479-492.
Naassila M, Ledent C, Daoust M (2002) Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 22:10487-10493.
Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46:243-253.
Oswald L. M. and Wand G. S. (2004) Opioids and alcoholism. Physiol Behav 81:339-358.
Phillips T. J., Brown K. J., Burkhart-Kasch S., Wenger C. D., Kelly M. A., Rubinstein M., et al. (1998) Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci 1:610-615.
Pucilowski O, Ayensu WK, D'Ercole AJ (1996) Insulin-like growth factor I expression alters acute sensitivity and tolerance to ethanol in transgenic mice. Eur J Pharmacol 305:57-62.
Rezvani AH, Grady DR, Janowsky DS (1991) Effect of calcium-channel blockers on alcohol consumption in alcohol-drinking monkeys. Alcohol & Alcoholism 26:161-167.
Rezvani AH, Janowsky DS (1990) Decreased alcohol consumption by verapamil in alcohol preferring rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14:623-631.
Risinger FO, Boyce JM (2002) Conditioning tastant and the acquisition of conditioned taste avoidance to drugs of abuse in DBA/2J mice. Psychopharmacology (Berl) 160:225-232.
Roberts A. J., McDonald J. S., Heyser C. J., Kieffer B. L., Matthes H. W., Koob G. F., et al. (2000) mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293:1002-1008.
Ruiz-Velasco and Ikeda (2000) Multiple G-Protein βγ Combinations Produce Voltage-Dependent Inhibition of N-Type Calcium Channels in Rat Superior Cervical Ganglion Neurons. J. Neuroscience 20:2183-91.
Soldo BL, Moises HC (1997) μ-opioid receptor activation decreases N-type Ca2+ current in magnocellular neurons of the rat basal forebrain. Brain Research 758:118-126.
Solem M, McMahon T, Messing RO (1997) Protein kinase A regulates inhibition of N- and P/Q-type calcium channels by ethanol in PC12 cells. Journal of Pharmacology and Experimental Therapeutics 282:1487-1495.
Spanagel R, Siegmund S, Cowen M, Schroff KC, Schumann G, Fiserova M, Sillaber I, Wellek S, Singer M, Putzke J (2002) The neuronal nitric oxide synthase gene is critically involved in neurobehavioral effects of alcohol. J Neurosci 22:8676-8683.
Thiele TE, Koh M
Messing Robert O.
Newton Philip M.
Jones Day
Mondesi Robert B.
The Regents of the University of California
LandOfFree
Methods for modulating a drug-related effect or behavior does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modulating a drug-related effect or behavior, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating a drug-related effect or behavior will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2794797